Posts
January 31 2024
SINTX Technologies, Inc. an original equipment manufacturer of advanced ceramics, announced the pricing of its public offering in the amount of $4,000,000. EGS acted as counsel to Maxim Group LLC, sole placement agent in connection with the offering.
January 31 2024
Deep Medicine Acquisition Corp., a publicly traded special purpose acquisition company, and TruGolf Inc., among the leading sellers and distributors of golf simulator software and hardware with headquarters in Salt Lake City, Utah, announced the closing of their previously announced business combination. In connection with the consummation of the business combination, the combined public company was renamed “TruGolf Holdings, Inc.” The transaction is valued at approximately $125,000,000. EGS acted as counsel to Deep Medicine Acquisition Corp.
January 30 2024
Digital Brands Group, Inc. announced the commencement of its At The Market Offering in the amount of $1,806,937. EG&S acted as counsel to the Sales Agent.
January 29 2024
SeaStar Medical Holding Corporation, a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announced the pricing of its registered direct offering in the amount of $9,000,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent for the offering.
January 28 2024
Processa Pharmaceuticals, Inc. announced the closing of its Public Offering in the amount of $7,000,000. EG&S acted as counsel to the Placement Agent.
January 26 2024
Client Alert: Employers to Provide a “Workers’ Bill of Rights” to All Employees Beginning July 1, 2024
New York City has enacted a law requiring all employers to provide their employees with a Worker’s Bill of Rights beginning on July 1, 2024. Employers will have to post and distribute it to all employees, regardless of immigration status.
Click here to read the alert.
January 26 2024
Akoustis Technologies, Inc. announced the closing of its Underwritten Public Offering in the amount of $11,500,000. EG&S acted as counsel to the Underwriter.
January 26 2024
Processa Pharmaceuticals, Inc. announced the closing of its Public Offering in the amount of $7,000,000. EG&S acted as counsel to the Placement Agent.